Sign inSign in

Pasi Jänne

Director · Yale University

Pasi Jänne directs the Lowe Center for Thoracic Oncology at Dana-Farber and co-discovered EGFR mutations predicting lung cancer response to gefitinib.

More

Pasi Jänne directs the Lowe Center for Thoracic Oncology at Dana-Farber and co-discovered EGFR mutations predicting lung cancer response to gefitinib. At Yale grand rounds, Jänne traces, at research level, how drug-tolerant persister cells survive EGFR inhibition via BCL-XL and YAP signaling.

About

Pasi Jänne directs the Lowe Center for Thoracic Oncology at Dana-Farber and co-discovered EGFR mutations predicting lung cancer response to gefitinib. At Yale grand rounds, Jänne traces, at research level, how drug-tolerant persister cells survive EGFR inhibition via BCL-XL and YAP signaling.

Connections

6

Their places, courses, books and lectures.